Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial).
Ng SP, Chu J, Chander S, Bressel M, McKendrick J, Wong R, Steel M, Murray WK, Leong T, Heriot A, Michael M, Ngan SY. Ng SP, et al. Among authors: mckendrick j. Radiother Oncol. 2021 Feb;155:27-32. doi: 10.1016/j.radonc.2020.10.012. Epub 2020 Oct 14. Radiother Oncol. 2021. PMID: 33065186 Clinical Trial.
Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.
Michael M, Chander S, McKendrick J, MacKay JR, Steel M, Hicks R, Heriot A, Leong T, Cooray P, Jefford M, Zalcberg J, Bressel M, McClure B, Ngan SY. Michael M, et al. Among authors: mckendrick j. Br J Cancer. 2014 Nov 11;111(10):1924-31. doi: 10.1038/bjc.2014.487. Epub 2014 Sep 11. Br J Cancer. 2014. PMID: 25211659 Free PMC article. Clinical Trial.
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA, McKendrick J, Leong T, Hartopeanu C, Zalcberg J, Mackay J. Ngan SY, et al. Among authors: mckendrick j. J Clin Oncol. 2012 Nov 1;30(31):3827-33. doi: 10.1200/JCO.2012.42.9597. Epub 2012 Sep 24. J Clin Oncol. 2012. PMID: 23008301 Clinical Trial.
The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
McLachlan SA, Fisher RJ, Zalcberg J, Solomon M, Burmeister B, Goldstein D, Leong T, Ackland SP, McKendrick J, McClure B, Mackay J, Ngan SY. McLachlan SA, et al. Among authors: mckendrick j. Eur J Cancer. 2016 Mar;55:15-26. doi: 10.1016/j.ejca.2015.10.060. Epub 2016 Jan 7. Eur J Cancer. 2016. PMID: 26771873 Clinical Trial.
Tolerability of accelerated chest irradiation and impact on survival of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer: review of a single institution's experience.
Ng M, Chong J, Milner A, MacManus M, Wheeler G, Wirth A, Michael M, Ganju V, McKendrick J, Ball D. Ng M, et al. Among authors: mckendrick j. J Thorac Oncol. 2007 Jun;2(6):506-13. doi: 10.1097/JTO.0b013e318060095b. J Thorac Oncol. 2007. PMID: 17545845 Free article.
157 results